Global Public Health Problem: Hypertension
Journal of Pharmaceutical Research International,
Page 20-25
DOI:
10.9734/jpri/2020/v32i4031030
Abstract
Hypertension is a big global public health problem. This research concentrates on exploring hypertension prevalence and its related causes in a Yemetu community located at Oyo States’ local in Nigeria. Hypertension is one of the most significant risk factor for cardiovascular disease. Growing on hydroxyl-butyrate as the primary source of carbon and nitrogen offered a strong competition for clones carrying new degrading enzymes, and antibiotic resistance competition established new determinants of antibiotic resistance from soil and oral flora. A descriptive & cross-sectional design was referred. Research included 804 participants of 171 households aged 18-90 years, chosen by cluster sampling methodology. It was a survey of the building to the building. World Health Organization (WHO) used STEP smart approach for tracking risk factors for chronic diseases (STEPS 1 & 2) to assess behavioral risk factors. Systolic blood pressure was described as hypertension. Overall hypertension prevalence was 33.1 percent (36.8 percent for males and 31.1 percent for females). The percentage of hypertension that is self-reported is 12.2%, as anti-hypertensive treatment actually accounted for 5.1%. The respondents mean age is 38.7 ±14.5 years. Respondents' BMI found to be 6.3%, 53.0%, 30.5% and 14.2% respectively for underweight, average, overweight and obese.
Keywords:
- Hypertension
- blood pressure
- prevalence
- education
- awareness
- health
- cardiac attack
- life style
How to Cite
References
American college of obstetricians and task force on hypertension in pregnancy, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy., in Obstetrics and Gynecology; 2013.
DOI:10.1097/01.AOG.0000437382.03963.88
Sanad MH, Ebtisam AM, Safaa BC. Radioiodination of olmesartan medoxomil and biological evaluation of the product as a tracer for cardiac imaging. Radiochim. Acta. 2018;106:329.
Sanad MH, Alhussein A. Radioiodination, diagnostic nuclear imaging and bioevaluation of olmesartan as a tracer for cardiac imaging. Radiochim. Acta. 2018;106:843.
Sanad MH, Sallam KM, Marzook FA, Abd-Elhaliem SM. Radioiodination and biological evaluation of candesartan as a tracer for cardiovascular disorder detection. J. Label. Compd.Radiopharm. 2016;59:484.
Sanad MH, Marzook FA, Abd-Elhaliem SM. Radioiodination and biological evaluation of irbesartan as a tracer for cardiac imaging. Radiochim. Acta.
DOI: 10.1515/ract-2020-00252020
Wolf J, Somers VK, Narkiewicz K. Hyper-tension, in Encyclopedia of Sleep; 2013.
Vysočanová M, Floriánová A, Špinar J. Hypertension in pregnancy. Kardiol. Rev.; 2018.
DOI: 10.7175/cmi.v1i1.615
Hasebe N. Hypertension. Nihon Rinsho; 2015.
DOI: 10.7748/ns2003.12.18.13.45.c3517
Hoeper MM, et al. Definitions and diagnosis of pulmonary hypertension. In Journal of the American College of Cardiology; 2013.
DOI: 10.1016/j.jacc.2013.10.032
Arden C. The ESH/ESC guidelines for the management of arterial hypertension. Primary Care Cardiovascular Journal; 2014.
DOI: 10.3132/pccj.2014.011
Medications BP, Changes M. Treatment of Hypertension: JNC 8 and More, Res. Cent.; 2014.
Javaroni V, Neves MF. Erectile dysfunction and hypertension: Impact on cardio-vascular risk and treatment, International Journal of Hypertension; 2012.
DOI: 10.1155/2012/627278
Chazova IE, Dongre N, Vigdorchik AV. Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension, Adv. Ther. 2011.
DOI: 10.1007/s12325-010-0099-1
-
Abstract View: 63 times
PDF Download: 60 times
